ID
38162
Beschrijving
Study ID: 105-123 Clinical Study ID: 105-123 Study Title: Lamotrigine as add-on therapy in patients with clinical diagnosis of a Lennox-Gastaut syndrome (severe generalised epilepsy of childhood onset.) A multicentre, double-blind, placebo controlled parallel group study Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Sponsor: GlaxoSmithKline Phase: Phase 3 Study Recruitment Status: Completed Generic Name: Lamotrigine Study Indication: Seizures
Trefwoorden
Versies (1)
- 23-09-19 23-09-19 -
Houder van rechten
GlaxoSmithKline
Geüploaded op
23 september 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Lamotrigine as add-on therapy in patients with a clinical diagnosis of a Lennox-Gastaut syndrome (105-123)
Comment Log; Investigator's Statement
- StudyEvent: ODM
Beschrijving
Comment Log
Alias
- UMLS CUI-1
- C0947611
Beschrijving
Investigator's Statement
Alias
- UMLS CUI-1
- C0008961
- UMLS CUI-2
- C1710187
Beschrijving
I confirm that I have carefully examined all entries on the Case Report Forms for this patient. All Information entered by myself or my colleagues is, to the best of my knowledge, correct as of the date below.
Datatype
text
Alias
- UMLS CUI [1,1]
- C1519316
- UMLS CUI [1,2]
- C1521895
Beschrijving
Principal Investigator's Name
Datatype
text
Alias
- UMLS CUI [1]
- C2826892
Beschrijving
Signature Date
Datatype
date
Alias
- UMLS CUI [1,1]
- C2346576
- UMLS CUI [1,2]
- C0011008
Similar models
Comment Log; Investigator's Statement
- StudyEvent: ODM
C0600091 (UMLS CUI [1,2])
C1710187 (UMLS CUI-2)
C1521895 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
Geen commentaren